A new window of opportunity to reject process-based biotechnology regulation

Gary Marchant, Yvonne A. Stevens

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

The question of whether biotechnology regulation should be based on the process or the product has long been debated, with different jurisdictions adopting different approaches. The European Union has adopted a process-based approach, Canada has adopted a product-based approach, and the United States has implemented a hybrid system. With the recent proliferation of new methods of genetic modification, such as gene editing, process-based regulatory systems, which are premised on a binary system of transgenic and conventional approaches, will become increasingly obsolete and unsustainable. To avoid unreasonable, unfair and arbitrary results, nations that have adopted process-based approaches will need to migrate to a product-based approach that considers the novelty and risks of the individual trait, rather than the process by which that trait was produced. This commentary suggests some approaches for the design of such a product-based approach.

Original languageEnglish (US)
Pages (from-to)233-242
Number of pages10
JournalGM crops & food
Volume6
Issue number4
DOIs
StatePublished - 2015

Keywords

  • biotechnology, regulation, process-based, product-based, gene editing

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'A new window of opportunity to reject process-based biotechnology regulation'. Together they form a unique fingerprint.

  • Cite this